All Pharma News
Nkarta Announces Pricing of $240 Million Underwritten Offering

Nkarta Announces Pricing of $240 Million Underwritten Offering
GLOBENEWSWIRE
25 Mar 2024
Share Share
Nkarta`s blood cancer CAR stalls again, driving deprioritization

Nkarta`s blood cancer CAR stalls again, driving deprioritization
Nick Paul Taylor FIERCE BIOTECH
23 Mar 2024
Share Share
Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results

Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
21 Mar 2024
Share Share
Nkarta Presents NKX101 Clinical Data at the 2023 Annual Meeting & Exposition

Nkarta Presents NKX101 Clinical Data at the 2023 Annual Meeting & Exposition
GLOBENEWSWIRE
09 Dec 2023
Share Share
Nkarta to Participate at Upcoming Investor Conferences

Nkarta to Participate at Upcoming Investor Conferences
GLOBENEWSWIRE
07 Nov 2023
Share Share
Nkarta moves cell therapy into autoimmune trials, lays off staff

Nkarta moves cell therapy into autoimmune trials, lays off staff
Gabrielle Masson FIERCE BIOTECH
18 Oct 2023
Share Share
Nkarta trims headcount as it sets sights on autoimmune cell therapy

Nkarta trims headcount as it sets sights on autoimmune cell therapy
Kyle LaHucik ENDPTS
17 Oct 2023
Share Share
Ex-Nkarta exec Nadir Mahmood to lead UCSF spinout Rezo

Ex-Nkarta exec Nadir Mahmood to lead UCSF spinout Rezo
Max Bayer FIERCE BIOTECH
20 Sep 2023
Share Share
Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights

Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights
GLOBENEWSWIRE
10 Aug 2023
Share Share
Nkarta to Participate at Upcoming Investor Conference

Nkarta to Participate at Upcoming Investor Conference
GLOBENEWSWIRE
03 Aug 2023
Share Share